In this sense, T cells transduced to express this CAR, efficiently killed CEA+ cells in vitro, and inhibited the growth of CRC tumors in vivo, but unfortunately the trial was prematurely closed due to lack of prolonged CAR T cell persistence and acute respiratory toxicity64. The gene discussed is CEACAM5; the disease is colorectal carcinoma.